Glen Eagle Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $208 | Hold |
17
| – | – | ﹤0.01% | 1015 |
|
2025
Q1 | $244 | Hold |
17
| – | – | ﹤0.01% | 1029 |
|
2024
Q4 | $271 | Hold |
17
| – | – | ﹤0.01% | 1053 |
|
2024
Q3 | $409 | Hold |
17
| – | – | ﹤0.01% | 1079 |
|
2024
Q2 | $339 | Hold |
17
| – | – | ﹤0.01% | 1083 |
|
2024
Q1 | $338 | Hold |
17
| – | – | ﹤0.01% | 1045 |
|
2023
Q4 | $381 | Hold |
17
| – | – | ﹤0.01% | 980 |
|
2023
Q3 | $344 | Hold |
17
| – | – | ﹤0.01% | 983 |
|
2023
Q2 | $435 | Sell |
17
-3
| -15% | -$77 | ﹤0.01% | 1010 |
|
2023
Q1 | $595 | Buy |
20
+3
| +18% | +$89 | ﹤0.01% | 993 |
|
2022
Q4 | $460 | Hold |
17
| – | – | ﹤0.01% | 1089 |
|
2022
Q3 | $370 | Hold |
17
| – | – | ﹤0.01% | 1037 |
|
2022
Q2 | $465 | Hold |
17
| – | – | ﹤0.01% | 946 |
|
2022
Q1 | $570 | Hold |
17
| – | – | ﹤0.01% | 899 |
|
2021
Q4 | $589 | Hold |
17
| – | – | ﹤0.01% | 883 |
|
2021
Q3 | $530 | Hold |
17
| – | – | ﹤0.01% | 1013 |
|
2021
Q2 | $618 | Hold |
17
| – | – | ﹤0.01% | 991 |
|
2021
Q1 | $744 | Hold |
17
| – | – | ﹤0.01% | 953 |
|
2020
Q4 | $780 | Hold |
17
| – | – | ﹤0.01% | 921 |
|
2020
Q3 | $565 | Buy |
+17
| New | +$565 | ﹤0.01% | 876 |
|